Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 95 | 4,474−6.6%/yr | −6.6%/yr | 3.21.3× | 2% | 4,650 in 2030+0.6%/yr |
| Lumbar fusion | 89 | 3,644−1.8%/yr | −1.8%/yr | 2.61.4× | 3% | 3,820 in 2030+0.8%/yr |
| Cervical fusion & disc arthroplasty | 23 | 1,803−4.6%/yr | −4.6%/yr | 1.31.3× | 0% | 1,920 in 2030+1%/yr |
| Kyphoplasty & vertebroplasty | 13 | 1,396−2.9%/yr | −2.9%/yr | 1.01.3× | 12% | 1,330 in 2030−0.7%/yr |
| SI joint fusion | 3 | 212+10%/yr | +10%/yr | 0.11.4× | 16% | 590 in 2030+19%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 643 | 120,771−1.4%/yr | −1.4%/yr | 84.30.9× | 52% | 123,700 in 2030+0.4%/yr |
| Skin substitutes & wound grafts | 30 | 9,758+2.6%/yr | +2.6%/yr | 4.20.8× | 75% | 13,200 in 2030+5.2%/yr |
| Bone graft & orthobiologics | 25 | 1,024−12%/yr | −12%/yr | 0.71.9× | 0% | 1,010 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 205 | 12,153+2.9%/yr | +2.9%/yr | 8.51.2× | 63% | 14,300 in 2030+2.7%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 15 | 1,231+6.1%/yr | +6.1%/yr | 0.81.3× | 44% | 1,540 in 2030+3.8%/yr |
| Spinal cord & DRG stimulation | 32 | 1,028−1.4%/yr | −1.4%/yr | 0.72.5× | 32% | 980 in 2030−0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 59 | 4,916−14%/yr | −14%/yr | 3.80.6× | 50% | 4,300 in 2030−2.2%/yr |
| Peripheral arterial intervention | 34 | 4,796−11%/yr | −11%/yr | 3.30.6× | 15% | 4,870 in 2030+0.3%/yr |
| Superficial venous ablation | 45 | 3,315−8.9%/yr | −8.9%/yr | 2.30.6× | 87% | 3,220 in 2030−0.5%/yr |
| Thrombectomy, IVC filters & venous stents | 14 | 1,998+1.6%/yr | +1.6%/yr | 1.51.1× | 9% | 2,310 in 2030+2.4%/yr |
| Carotid revascularization | 23 | 1,666−3.1%/yr | −3.1%/yr | 1.21.3× | 0% | 1,760 in 2030+0.9%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 705−5.5%/yr | −5.5%/yr | 0.51.3× | 0% | 710 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 114 | 8,075−2.5%/yr | −2.5%/yr | 6.31.1× | 4% | 8,470 in 2030+0.8%/yr |
| Cholecystectomy & appendectomy | 95 | 5,634−4%/yr | −4%/yr | 4.31.3× | 1% | 5,840 in 2030+0.6%/yr |
| Colorectal resection | 12 | 2,424−5.6%/yr | −5.6%/yr | 1.81.2× | 0% | 2,120 in 2030−2.2%/yr |
| Antireflux & hiatal hernia surgery | 16 | 1,062−0.9%/yr | −0.9%/yr | 0.81.4× | 0% | 960 in 2030−1.6%/yr |
| Breast reconstruction | 1 | 565−8.2%/yr | −8.2%/yr | 0.41.0× | 0% | 800 in 2030+6.1%/yr |
| Bariatric surgery | 0 | 197−22%/yr | −22%/yr | 0.10.8× | 0% | 190 in 2030−0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 164 | 6,776−2%/yr | −2%/yr | 5.00.9× | 12% | 6,810 in 2030+0.1%/yr |
| BPH procedures | 78 | 5,698−7.3%/yr | −7.3%/yr | 4.21.0× | 31% | 4,890 in 2030−2.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 52 | 4,366−2%/yr | −2%/yr | 3.51.1× | 10% | 4,620 in 2030+0.9%/yr |
| Incontinence, prolapse & sacral neuromodulation | 45 | 2,928+2.4%/yr | +2.4%/yr | 2.11.2× | 8% | 3,450 in 2030+2.8%/yr |
| Prostatectomy & nephrectomy | 27 | 1,659−0.2%/yr | −0.2%/yr | 1.31.2× | 0% | 1,900 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 51 | 5,134−4.5%/yr | −4.5%/yr | 3.81.2× | 58% | 5,170 in 2030+0.1%/yr |
| Ear tubes & middle ear surgery | 8 | 528−9.9%/yr | −9.9%/yr | 0.42.0× | 47% | 490 in 2030−1.1%/yr |
| Sleep apnea & airway implants | 8 | 263+58%/yr | +58%/yr | 0.22.1× | 0% | 300 in 2030+2.1%/yr |
| Cochlear implants | 4 | 159+3.5%/yr | +3.5%/yr | 0.11.4× | 0% | 150 in 2030−1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 180 | 9,684−1.2%/yr | −1.2%/yr | 7.60.9× | 8% | 10,100 in 2030+0.8%/yr |
| Tumor & fibroid embolization | 19 | 908−0.7%/yr | −0.7%/yr | 0.71.1× | 27% | 1,830 in 2030+12%/yr |
| Tumor ablation | 3 | 418+0.9%/yr | +0.9%/yr | 0.31.1× | 0% | 330 in 2030−3.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 334 | 37,842+26%/yr | +26%/yr | 27.20.9× | 80% | 63,900 in 2030+9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 147 | 7,396−2.8%/yr | −2.8%/yr | 5.61.2× | 2% | 6,810 in 2030−1.4%/yr |
| EP ablation | 131 | 5,803+11%/yr | +11%/yr | 3.51.1× | 0% | 11,400 in 2030+12%/yr |
| LAA occlusion & loop recorders | 139 | 4,787+8.9%/yr | +8.9%/yr | 3.00.9× | 14% | 7,520 in 2030+7.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 224 | 8,394−5.9%/yr | −5.9%/yr | 5.01.0× | 1% | 8,320 in 2030−0.1%/yr |
| Structural heart (TAVR, TEER) | 158 | 2,820+2.5%/yr | +2.5%/yr | 1.70.9× | 0% | 3,580 in 2030+4%/yr |
| Mechanical circulatory support | 2 | 838−4.5%/yr | −4.5%/yr | 0.61.1× | 0% | 950 in 2030+2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 29 | 803+20%/yr | +20%/yr | 0.61.1× | 0% | 1,470 in 2030+11%/yr |
| Stroke thrombectomy | 30 | 767+7.4%/yr | +7.4%/yr | 0.61.5× | 0% | 1,030 in 2030+5%/yr |
| DBS & VNS | 4 | 485−4.3%/yr | −4.3%/yr | 0.31.5× | 0% | 620 in 2030+4.1%/yr |
| CSF shunts | 2 | 238−9.5%/yr | −9.5%/yr | 0.20.8× | 0% | 280 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 390 | 72,726−1.7%/yr | −1.7%/yr | 52.41.1× | 80% | 74,300 in 2030+0.4%/yr |
| Vitreoretinal surgery | 45 | 3,182−0.1%/yr | −0.1%/yr | 2.41.3× | 49% | 3,020 in 2030−0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 915 | 164,346−1.8%/yr | −1.8%/yr | 125.51.0× | 44% | 166,800 in 2030+0.2%/yr |
| ERCP & endoscopic ultrasound | 86 | 5,501−2.6%/yr | −2.6%/yr | 4.11.2× | 1% | 6,190 in 2030+2%/yr |
| Bronchoscopy & lung nodule | 75 | 5,343+1.2%/yr | +1.2%/yr | 4.01.5× | 0% | 7,380 in 2030+5.5%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.